Patent · US Active

Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates

US9610339B2 · kind B2 · utility

9Cited by

6References

16Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Ralph Leon Biemans · Rixensart, BE
Nathalie Garcon · Rixensart, BE
Philippe Vincent Hermand · Rixensart, BE
Jan Poolman · Broek in Waterland, NL
Marcelle Paulette Van Mechelen · Rixensart, BE

Key dates

Filing date	Jun 24, 2008
Grant date	Apr 4, 2017
Priority date	—
Expiry date	Jul 16, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an immunogenic composition comprising S. pneumoniae capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Methods of making and uses thereof are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.